Brannagan, Thomas. 2002. Intravenous gammaglobulin (IvIg) for treatment of CIDP and related immune-mediated neuropathies. Neurology. 59:12 (S33-40)

Guillain-Barre Syndrome Support Group Information Page. Last updated 1997. Accessed April 20, 2003. (

Janeway, C., Travers, P. Walport, M., Shlomchik, M. 2001. Immunobiology: The Immune System in Health and Disease. New York, New York: Garland Publishing.

Mahad, DJ, Howell, SJL, Woodroofe, MN. 2002. Expression of chemokines in cervrospinal fluid and serum of patients iwth chronic inflammatory demyelinating polyneuropathy. Journal of Neurosurgery and Psychiatry. 73:320-323

National Institute of Neurological Disorders and Stroke (NINDS).Chronic Inflammatory Demyelinating Polyneuropathy Information Page. Last updated July 1, 2001. Accessed: April 15, 2003. (

Ochi, Kazuhide, Kohriyama, Tatsuo, Hagaki, Masahiro, Ikeda, Junko, Harada, Akira, Nakamura, Shigenobu. 2003. Changes in Serum macrophage-related factors in patients with chronic inflammatory demyelinating polyneuropathy caused by intravenous immunolgobulin therapy. Journal of the Neurological Sciences. 208:43-50

van Doorn, Pieter. Chronic Inflammatory Demyelinating Polyneuropathy. Treatment of Nuerological Disorders with Intravenous Immunoglobulins. 2000. London Martin Dunitz Ltd.

Washington Univerisity Neuromuscular Disease Center. last updated February 2, 2003. Acccessed: April 15, 2003. (

( accessed April 25, 2003